Progress in Study on Drug Design of Conotoxins

CHEN Xiang,ZHU Yong-ping
DOI: https://doi.org/10.19526/j.cnki.1005-8915.2010.03.021
2010-01-01
Abstract:The conotoxins have a typical biological activity which modulates the ion channels in cellmembranes and neurotransmitter/bradykinin receptors.Conotoxins have novel structure and unique feature,with low molecular weight,which are easy to be used to build model of the molecular structure-activity relationship studies of new drugs design.However they are incovenient for clinical administration,due to stable and low absorption rate,which has also become one of main objectives of the drug design study.At present,a series of conotoxin analogues with certain activity have been designed and some have been in the stage of clinical study.These studies show that the conotoxins have a good prospect for development and application.The recently published articles on conotoxins drug design and the chemical modification or computer-aided design optimization in CTX drug design are analysed and summarized in the paper.
What problem does this paper attempt to address?